Sterol Carrier Protein‐2/Sterol Carrier Protein‐x/Fatty Acid Binding Protein‐1 Ablation Impacts Response of Brain Endocannabinoid to High‐Fat Diet. Issue 10 (5th September 2019)
- Record Type:
- Journal Article
- Title:
- Sterol Carrier Protein‐2/Sterol Carrier Protein‐x/Fatty Acid Binding Protein‐1 Ablation Impacts Response of Brain Endocannabinoid to High‐Fat Diet. Issue 10 (5th September 2019)
- Main Title:
- Sterol Carrier Protein‐2/Sterol Carrier Protein‐x/Fatty Acid Binding Protein‐1 Ablation Impacts Response of Brain Endocannabinoid to High‐Fat Diet
- Authors:
- Martin, Gregory G.
Seeger, Drew R.
McIntosh, Avery L.
Milligan, Sherrelle
Chung, Sarah
Landrock, Danilo
Dangott, Lawrence J.
Golovko, Mikhail Y.
Murphy, Eric J.
Kier, Ann B.
Schroeder, Friedhelm - Abstract:
- Abstract: Brain endocannabinoids (EC) such as arachidonoylethanolamine (AEA) and 2‐arachidonoylglycerol (2‐AG) primarily originate from serum arachidonic acid (ARA), whose level is regulated in part by a cytosolic ARA‐binding protein, that is, liver fatty acid binding protein‐1 (FABP1), not expressed in the brain. Ablation of the Fabp1 gene (LKO) increases brain AEA and 2‐AG by decreasing hepatic uptake of ARA to increase serum ARA, thereby increasing ARA availability for uptake by the brain. The brain also expresses sterol carrier protein‐2 (SCP‐2), which is also a cytosolic ARA‐binding protein. To further resolve the role of SCP‐2 independent of FABP1, mice ablated in the Scp‐2/Scp‐x gene (DKO) were crossed with mice ablated in the Fabp1 gene (LKO) mice to generate triple knock out (TKO) mice. TKO impaired the ability of LKO to increase brain AEA and 2‐AG. While a high‐fat diet (HFD) alone increased brain AEA, TKO impaired this effect. Overall, these TKO‐induced blocks were not attributable to altered expression of brain proteins in ARA uptake, AEA/2‐AG synthesis, or AEA/2‐AG degrading enzymes. Instead, TKO reduced serum levels of free ARA and/or total ARA and thereby decreased ARA availability for uptake to the brain and downstream synthesis of AEA and 2‐AG therein. In summary, Scp‐2/Scp‐x gene ablation in Fabp1 null (LKO) mice antagonized the impact of LKO and HFD on brain ARA and, subsequently, EC levels. Thus, both FABP1 and SCP‐2 participate in regulating the ECAbstract: Brain endocannabinoids (EC) such as arachidonoylethanolamine (AEA) and 2‐arachidonoylglycerol (2‐AG) primarily originate from serum arachidonic acid (ARA), whose level is regulated in part by a cytosolic ARA‐binding protein, that is, liver fatty acid binding protein‐1 (FABP1), not expressed in the brain. Ablation of the Fabp1 gene (LKO) increases brain AEA and 2‐AG by decreasing hepatic uptake of ARA to increase serum ARA, thereby increasing ARA availability for uptake by the brain. The brain also expresses sterol carrier protein‐2 (SCP‐2), which is also a cytosolic ARA‐binding protein. To further resolve the role of SCP‐2 independent of FABP1, mice ablated in the Scp‐2/Scp‐x gene (DKO) were crossed with mice ablated in the Fabp1 gene (LKO) mice to generate triple knock out (TKO) mice. TKO impaired the ability of LKO to increase brain AEA and 2‐AG. While a high‐fat diet (HFD) alone increased brain AEA, TKO impaired this effect. Overall, these TKO‐induced blocks were not attributable to altered expression of brain proteins in ARA uptake, AEA/2‐AG synthesis, or AEA/2‐AG degrading enzymes. Instead, TKO reduced serum levels of free ARA and/or total ARA and thereby decreased ARA availability for uptake to the brain and downstream synthesis of AEA and 2‐AG therein. In summary, Scp‐2/Scp‐x gene ablation in Fabp1 null (LKO) mice antagonized the impact of LKO and HFD on brain ARA and, subsequently, EC levels. Thus, both FABP1 and SCP‐2 participate in regulating the EC system in the brain. … (more)
- Is Part Of:
- Lipids. Volume 54:Issue 10(2019)
- Journal:
- Lipids
- Issue:
- Volume 54:Issue 10(2019)
- Issue Display:
- Volume 54, Issue 10 (2019)
- Year:
- 2019
- Volume:
- 54
- Issue:
- 10
- Issue Sort Value:
- 2019-0054-0010-0000
- Page Start:
- 583
- Page End:
- 601
- Publication Date:
- 2019-09-05
- Subjects:
- Endocannabinoid -- FABP1 -- Gene ablation -- High‐fat diet -- Mouse -- SCP‐2/SCP‐x
Lipids -- Periodicals
Lipids -- Periodicals
Lipiden
Lipides -- Périodiques
547.77 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0024-4201;screen=info;ECOIP ↗
http://link.springer.com/journal/11745 ↗
http://springerlink.metapress.com/content/120379/?p=67eb9addeb9a4d2a87ce760fbdd684eb&pi=0 ↗
http://www.springerlink.com/content/120379/ ↗
http://www.springer.com/gb/ ↗
http://www.aocs.org/press/ ↗ - DOI:
- 10.1002/lipd.12192 ↗
- Languages:
- English
- ISSNs:
- 0024-4201
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5221.850000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11854.xml